Image
Courtesy of NIDA
Opportunities
Beginning in fiscal year 2026, NIH will no longer post notices of funding opportunities in the NIH Guide. To find NIH notices of funding opportunities please explore the NIH Grant Opportunities search tool which links to grants.gov, NIH’s single official source for grant and cooperative agreement funding opportunities.
The NIH announcement stating this change can be read here: NOT-OD-25-143.
NIDA Research Priorities
- NIDA Funding Strategy – A review of NIDA’s strategy for funding, based on programmatic priorities.
- Notice of Special Interest (NOSI) - formerly known as Drug Abuse Topics of Special/Continuing Interest (DAT)
- National Advisory Council on Drug Abuse (NACDA) Approved Concepts – The purpose, scope, and objectives of approved concepts for potential funding opportunities.
- NIDA Challenges Program – Crowd-sourced opportunities for providing solutions for particular goals.
- Support for Research Training and Career Development – Grant funding opportunities for research training and career development at institutions across the country.
- Helping to End Addiction Long-term (HEAL) Initiative – Congressional initiative to address the opioid overdose crisis.
- NIDA International Program – International research collaboration opportunities on drug abuse and addiction.
See NIDA’s Resources for Grants & Contracts to learn more about applying for a grant and the pre-approval and approval process.
Administrative Supplements for Grants & Cooperative Agreements
- Administrative Supplements for Grants & Cooperative Agreements – Additional funding to an active NIDA grant or cooperative agreement.
Supplemental Information for NOFOs
- Pre-Application Information Virtual Presentation for Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) Notices of Funding Opportunities (RFA-DA-25-037 and RFA-DA-25-038)
- Supplemental Information for NOT-DA-22-064: Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access
- FAQs for Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders - RFA-DA-24-007.
- FAQs for Registry of Medical Cannabis Use and Health Outcomes: RFA-DA-23-011
- Supplemental Information for NIH Developmental Studies Biospecimen Access Program
- FAQs for Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders - RFA-DA-23-014
- Pre-Application Information Webinar for PAR-21-183, "Developing Digital Therapeutics for Substance Use Disorders
- FAQs Regarding Notice of Information: Establishment of a Standard THC Unit to be Used in Research (NOT-DA-21-049)
- Frequently Asked Questions about NOT-DA-21-041: Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
- RFA-DA-21-009: Pre-Application Webinar and FAQs- Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents
- Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research - RFA-DA-20-025
- FAQs for Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1)
- FAQs for NOT-DA-19-003: HEAL Initiative: Request for Administrative Supplements to Existing Grants to Accelerate Research on Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16-30)
- Supplemental Information (FAQs) for NIDA Research E-cigarette - PAR-17-156
- Supplemental Information (FAQs) for RFA-DA-17-014 and RFA-DA-17-023